• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    1/31/23 1:37:57 PM ET
    $IOSP
    Major Chemicals
    Industrials
    Get the next $IOSP alert in real time by email
    SC 13G/A 1 iosp8.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No.8) Innospec, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 45768S105 (CUSIP Number) Date of Event Which Requires Filing of this Statement: December 31, 2022 *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 45768S105 13G 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royce & Associates, LP 52-2343049 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 870,792 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 870,792 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 870,792 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.52% 12 TYPE OF REPORTING PERSON IA CUSIP No. 45768S105 13G Item 1(a) Name of Issuer: Innospec, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: Chief Financial Officer 8310 South Valley Highway Englewood, CO Item 2(a) Name of Persons Filing: Royce & Associates, LP Item 2(b) Address of Principal Business Office, or, if None, Residence: 745 Fifth Avenue, New York, NY 10151 Item 2(c) Citizenship: New York Corporation Item 2(d) Title of Class of Securities: Common Stock Item 2(e) CUSIP Number: 45768S105 Item 3 If this statement is filed pursuant to rules 13d-1(b), or 13d- 2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Act (b) [ ] Bank as defined in Section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d) [ ] Investment Company registered under Section 8 of the Investment Company Act (e) [X] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund (g) [ ] Parent Holding Company, in accordance with Rule 13d-1 (b)(ii)(G) (h) [ ] Group CUSIP No. 45768S105 13G Item 4 Ownership The securities reported herein are beneficially owned by one or more registered investment companies or other managed accounts that are investment management clients of Royce & Associates, LP ("RALP"), an indirect majority owned subsidiary of Franklin Resources, Inc.("FRI"). When an investment management contract (including a sub advisory agreement) delegates to RALP investment discretion or voting power over the securities held in the investment advisory accounts that are subject to that agreement, FRI treats RALP as having sole investment discretion or voting authority, as the case may be, unless the agreement specifies otherwise. Accordingly, RALP reports on Schedule 13G that it has sole investment discretion and voting authority over the securities covered by any such investment management agreement, unless otherwise noted in this Item 4. As a result, for purposes of Rule 13d 3 under the Act, RALP may be deemed to be the beneficial owner of the securities reported in this Schedule 13G. Beneficial ownership by investment management subsidiaries and other affiliates of FRI is being reported in conformity with the guidelines articulated by the SEC staff in Release No. 34 39538 (January 12, 1998) relating to organizations, such as FRI, where related entities exercise voting and investment powers over the securities being reported independently from each other. The voting and investment powers held by RALP are exercised independently from FRI (RALP's parent holding company) and from all other investment management subsidiaries of FRI (FRI, its affiliates and investment management subsidiaries other than RALP are, collectively, "FRI affiliates"). Furthermore, internal policies and procedures of RALP and FRI affiliates establish informational barriers that prevent the flow between RALP and the FRI affiliates of information that relates to the voting and investment powers over the securities owned by their respective investment management clients. Consequently, RALP and the FRI affiliates report the securities over which they hold investment and voting power separately from each other for purposes of Section 13 of the Act. Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") each own in excess of 10% of the outstanding common stock of FRI and are the principal stockholders of FRI. However, because RALP exercises voting and investment powers on behalf of its investment management clients independently of FRI affiliates, beneficial ownership of the securities reported by RALP is not attributed to the Principal Shareholders. RALP disclaims any pecuniary interest in any of the securities reported in this Schedule 13G. In addition, the filing of this Schedule 13G on behalf of RALP should not be construed as an admission that it is, and it disclaims that it is, the beneficial owner, as defined in Rule 13d 3, of any of such securities. Furthermore, RALP believes that it is not a "group" with FRI affiliates, the Principal Shareholders, or their respective affiliates within the meaning of Rule 13d 5 under the Act and that none of them is otherwise required to attribute to any other the beneficial ownership of the securities held by such person or by any persons or entities for whom or for which RALP or the FRI affiliates provide investment management services. (a) Amount Beneficially Owned: 870,792 (b) Percent of Class: 3.52% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 870,792 (ii) shared power to vote or to direct the vote __________ (iii) sole power to dispose or to direct the disposition of 870,792 (iv) shared power to dispose or to direct the disposition of __________ Item 5 Ownership of Five Percent or Less of a Class. [ X ] Item 6 Ownership of More than Five Percent on Behalf of Another Person. NONE Item 7 Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company. NOT APPLICABLE Item 8 Identification and Classification of Members of the Group. NOT APPLICABLE Item 9 Notice of Dissolution of Group. NOT APPLICABLE CUSIP No. 45768S105 13G Item 10 Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement with respect to it is true, complete and correct. Date: January 31, 2023 By: Daniel A. O'Byrne Vice President
    Get the next $IOSP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IOSP

    DatePrice TargetRatingAnalyst
    4/21/2025$115.00Neutral → Buy
    Seaport Research Partners
    3/30/2022Neutral
    Seaport Research Partners
    More analyst ratings

    $IOSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Parrette Leslie J sold $40,421 worth of shares (446 units at $90.63), decreasing direct ownership by 8% to 5,497 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/15/25 9:11:51 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SVP, HUMAN RESOURCES Griffin Hardy Louis Iii covered exercise/tax liability with 600 shares, decreasing direct ownership by 8% to 6,742 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/15/25 9:05:37 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SVP, Corporate Dev and IR Barnes Corbin covered exercise/tax liability with 740 shares, decreasing direct ownership by 8% to 8,998 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/15/25 9:01:11 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Leadership Updates

    Live Leadership Updates

    See more
    • Innospec Appoints Leslie J. Parrette as Non-Employee Director

      ENGLEWOOD, Colo., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it has appointed Mr. Leslie J. Parrette as a non-employee director, effective January 1, 2022. Mr. Parrette has 14 years experience in private practice as a corporate and transaction lawyer. He subsequently spent 20 years as General Counsel for public companies in domestic and international markets. Most recently, he served as Senior Vice President, General Counsel, Compliance Officer and Corporate Secretary of Novelis Inc., a leading producer of flat-rolled aluminum products and the world's largest recycler of aluminum. He is Founder and President of One Page Thinking, a data visualizatio

      12/6/21 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Innospec upgraded by Seaport Research Partners with a new price target

      Seaport Research Partners upgraded Innospec from Neutral to Buy and set a new price target of $115.00

      4/21/25 8:30:53 AM ET
      $IOSP
      Major Chemicals
      Industrials
    • Seaport Research Partners initiated coverage on Innospec

      Seaport Research Partners initiated coverage of Innospec with a rating of Neutral

      3/30/22 7:37:48 AM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Innospec Reports First Quarter 2025 Financial Results

      Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

      5/8/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Schedules First Quarter 2025 Earnings Release and Conference Call

      ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Friday, May 9, 2025, at 9:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which

      4/3/25 5:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Approves New $50MM Share Repurchase Program

      ENGLEWOOD, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announces that its Board of Directors has approved a new $50 million share repurchase program. The company's prior $50 million share repurchase program expired in the first quarter of 2025. Patrick S. Williams, President and Chief Executive Officer, said, "With over $289 million in net cash, we continue to have significant flexibility and balance sheet strength for further M&A, organic investment, dividend growth and share repurchases under this renewed buyback program." Purchases may be made from time to time at management's discretion. About Innospec Inc. Innospec Inc. is an international special

      3/10/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    SEC Filings

    See more
    • SEC Form SD filed by Innospec Inc.

      SD - INNOSPEC INC. (0001054905) (Filer)

      5/30/25 6:04:36 AM ET
      $IOSP
      Major Chemicals
      Industrials
    • SEC Form 8-K filed by Innospec Inc.

      8-K - INNOSPEC INC. (0001054905) (Filer)

      5/14/25 6:04:58 AM ET
      $IOSP
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Innospec Inc.

      SCHEDULE 13G/A - INNOSPEC INC. (0001054905) (Subject)

      5/13/25 3:37:53 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Financials

    Live finance-specific insights

    See more

    $IOSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Innospec Reports First Quarter 2025 Financial Results

      Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

      5/8/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Schedules First Quarter 2025 Earnings Release and Conference Call

      ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Friday, May 9, 2025, at 9:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which

      4/3/25 5:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Approves New $50MM Share Repurchase Program

      ENGLEWOOD, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announces that its Board of Directors has approved a new $50 million share repurchase program. The company's prior $50 million share repurchase program expired in the first quarter of 2025. Patrick S. Williams, President and Chief Executive Officer, said, "With over $289 million in net cash, we continue to have significant flexibility and balance sheet strength for further M&A, organic investment, dividend growth and share repurchases under this renewed buyback program." Purchases may be made from time to time at management's discretion. About Innospec Inc. Innospec Inc. is an international special

      3/10/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Director Parrette Leslie J bought $15,135 worth of shares (143 units at $105.84), increasing direct ownership by 3% to 4,734 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      8/14/24 6:31:38 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Parrette Leslie J bought $24,867 worth of shares (189 units at $131.57), increasing direct ownership by 4% to 4,591 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/20/24 6:07:17 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Parrette Leslie J bought $50,824 worth of shares (410 units at $123.96), increasing direct ownership by 13% to 3,620 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      2/23/24 6:19:14 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

      SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

      2/13/24 5:06:27 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

      SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

      2/9/24 2:18:58 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

      SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

      1/12/24 8:24:55 AM ET
      $IOSP
      Major Chemicals
      Industrials